Literature DB >> 27923483

Regulation of membrane type-1 matrix metalloproteinase activity and intracellular localization in clinical thoracic aortic aneurysms.

John S Ikonomidis1, Elizabeth K Nadeau1, Adam W Akerman1, Robert E Stroud1, Rupak Mukherjee2, Jeffrey A Jones3.   

Abstract

OBJECTIVE: Membrane type-1 matrix metalloproteinase (MT1-MMP) is elevated during thoracic aortic aneurysm (TAA) development in mouse models, and plays an important role in the activation of matrix metalloproteinase (MMP)-2 and the release of matrix- bound transforming growth factor-β. In this study, we tested the hypothesis that MT1-MMP is subject to protein kinase C (PKC)-mediated regulation, which alters intracellular trafficking and activity with TAAs.
METHODS: Levels of MMP-2, native and phosphorylated MT1-MMP, and PKC-δ were measured in aortic tissue from patients with small TAAs (<5 cm; n = 8) and large TAAs (>6.5 cm; n = 8), and compared with values measured in normal controls (n = 8). Cellular localization of green fluorescent protein (GFP)-tagged MT1-MMP was assessed in aortic fibroblasts isolated from control and 4-week TAA mice. The effects of PKC-mediated phosphorylation on MT1-MMP cellular localization and function (active MMP-2 vs phospo-Smad2 abundance) were assessed after treatment with a PKC activator (phorbol-12-myristate-13-acetate [PMA], 100 nM) with and without a PKC-δ-specific inhibitor (röttlerin, 3 μM).
RESULTS: Compared with controls, MT1-MMP abundance was increased in aortas from both TAA groups. Active MMP-2 was increased only in the large TAA group. The abundances of phosphorylated MT1-MMP and activated PKC-δ were enhanced in the small TAA group compared with the large TAA group. MT1-MMP was localized on the plasma membrane in aortic fibroblasts from control mice and in endosomes from TAA mice. Treatment with PMA induced MT1-MMP-GFP internalization, enhanced phospho-Smad2, and reduced MMP-2 activation, whereas röttlerin pretreatment inhibited these effects.
CONCLUSIONS: Phosphorylation of MT1-MMP mediates its activity through directing cellular localization, shifting its role from MMP-2 activation to intracellular signaling. Thus, targeted inhibition of MT1-MMP may have therapeutic relevance as an approach to attenuating TAA development. Copyright Â
© 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MT1-MMP; aneurysm; protein kinase C; remodeling; thoracic aorta

Mesh:

Substances:

Year:  2016        PMID: 27923483      PMCID: PMC5316335          DOI: 10.1016/j.jtcvs.2016.10.065

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  35 in total

1.  Cellular phenotype transformation occurs during thoracic aortic aneurysm development.

Authors:  Jeffrey A Jones; Juozas A Zavadzkas; Eileen I Chang; Nina Sheats; Christine Koval; Robert E Stroud; Francis G Spinale; John S Ikonomidis
Journal:  J Thorac Cardiovasc Surg       Date:  2010-03-09       Impact factor: 5.209

2.  The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP).

Authors:  Albert G Remacle; Dmitri V Rozanov; Peter C Baciu; Alexei V Chekanov; Vladislav S Golubkov; Alex Y Strongin
Journal:  J Cell Sci       Date:  2005-10-11       Impact factor: 5.285

3.  Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

Authors:  K Imai; E Ohuchi; T Aoki; H Nomura; Y Fujii; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

4.  Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.

Authors:  V Knäuper; H Will; C López-Otin; B Smith; S J Atkinson; H Stanton; R M Hembry; G Murphy
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

5.  Alterations in membrane type-1 matrix metalloproteinase abundance after the induction of thoracic aortic aneurysm in a murine model.

Authors:  Jeffrey A Jones; Jean Marie Ruddy; Shenikqua Bouges; Juozas A Zavadzkas; Theresa A Brinsa; Robert E Stroud; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-23       Impact factor: 4.733

6.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

Authors:  G Matthew Longo; Wanfen Xiong; Timothy C Greiner; Yong Zhao; Nicola Fiotti; B Timothy Baxter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 7.  Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.

Authors:  Jeffrey A Jones; Francis G Spinale; John S Ikonomidis
Journal:  J Vasc Res       Date:  2008-09-02       Impact factor: 1.934

8.  Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.

Authors:  Tomoko Komiyama; Julia M Coppola; Martha J Larsen; Marcian E van Dort; Brian D Ross; Robert Day; Alnawaz Rehemtulla; Robert S Fuller
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

9.  Alterations in aortic cellular constituents during thoracic aortic aneurysm development: myofibroblast-mediated vascular remodeling.

Authors:  Jeffrey A Jones; Christy Beck; John R Barbour; Jouzas A Zavadzkas; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

Review 10.  Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.

Authors:  Sara Sigismund; Stefano Confalonieri; Andrea Ciliberto; Simona Polo; Giorgio Scita; Pier Paolo Di Fiore
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

View more
  3 in total

1.  MT1-MMP evaluation in neointimal hyperplasia in the late follow-up after prosthesis implantation.

Authors:  Marta Bruczko; Tomasz Gogiel; Małgorzata Wolańska; Radosław Kowalewski; Krzysztof Sobolewski; Lech Romanowicz
Journal:  Int J Exp Pathol       Date:  2019-05-06       Impact factor: 1.925

2.  A potential key mechanism in ascending aortic aneurysm development: Detection of a linear relationship between MMP-14/TIMP-2 ratio and active MMP-2.

Authors:  Ramona Schmitt; Anke Tscheuschler; Philipp Laschinski; Xenia Uffelmann; Philipp Discher; Jana Fuchs; Maximilian Kreibich; Remi Peyronnet; Fabian A Kari
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 3.  Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.

Authors:  Jiabin Xu; Wenqiang Cao; Penglai Wang; Hong Liu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.